A business in context

JSPR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-07 · 8016 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-30 · 0001213900-26-106651 · Items 5.07

  2. 8-K/A · Current report

    Report date 2026-07-16 · 0001213900-26-106574 · Items 9.01

  3. 8-K/A · Current report

    Report date 2026-07-16 · 0001213900-26-105924 · Items 9.01

  4. 8-K · Current report

    Report date 2026-09-23 · 0001213900-26-104101 · Items 5.02

  5. DEF 14A · Proxy statement

    Report date 2026-09-30 · 0001213900-26-097572

  6. 8-K · Current report

    Report date 2026-08-21 · 0001213900-26-093979 · Items 1.01

  7. 8-K · Current report

    Report date 2026-08-14 · 0001213900-26-090055 · Items 2.02,9.01

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-089592

  9. 4 · Ownership change

    Report date 2026-07-31 · 0001213900-26-085192

  10. 4 · Ownership change

    Report date 2026-07-31 · 0001213900-26-085191

  11. 4 · Ownership change

    Report date 2026-07-31 · 0001213900-26-085190

  12. 4 · Ownership change

    Report date 2026-07-31 · 0001213900-26-085189

  13. 4 · Ownership change

    Report date 2026-07-31 · 0001213900-26-085188

  14. 8-K · Current report

    Report date 2026-07-31 · 0001213900-26-084687 · Items 5.07

  15. 8-K · Current report

    Report date 2026-07-31 · 0001213900-26-083563 · Items 8.01

  16. 4 · Ownership change

    Report date 2026-07-20 · 0001213900-26-080525

  17. 4 · Ownership change

    Report date 2026-07-16 · 0001213900-26-079764

  18. 8-K · Current report

    Report date 2026-07-16 · 0001213900-26-078887 · Items 1.01,2.01,3.02,5.02,5.03,7.01,9.01

  19. 8-K · Current report

    Report date 2026-07-16 · 0001213900-26-078781 · Items 7.01,9.01

  20. DEF 14A · Proxy statement

    Report date 2026-07-31 · 0001213900-26-068765

  21. 8-K · Current report

    Report date 2026-06-03 · 0001213900-26-066782 · Items 3.01

  22. 8-K · Current report

    Report date 2026-06-01 · 0001213900-26-063157 · Items 7.01,9.01

  23. 8-K · Current report

    Report date 2026-05-15 · 0001213900-26-060029 · Items 5.02,9.01

  24. 8-K · Current report

    Report date 2026-05-14 · 0001213900-26-056596 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-056595

  26. 10-K/A · Annual report

    Report date 2025-12-31 · 0001213900-26-050178

  27. 8-K · Current report

    Report date 2026-03-30 · 0001213900-26-036448 · Items 2.02,9.01

  28. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-036426

  29. 4 · Ownership change

    Report date 2026-02-06 · 0001213900-26-014244

  30. 8-K · Current report

    Report date 2026-01-08 · 0001213900-26-002329 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2026-01-02 · 0001213900-26-002185 · Items 5.02,8.01,9.01

  32. 8-K · Current report

    Report date 2025-12-02 · 0001213900-25-116943 · Items 8.01,9.01

  33. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-107884

  34. 8-K · Current report

    Report date 2025-11-10 · 0001213900-25-107874 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-09-18 · 0001213900-25-089584 · Items 1.01,8.01,9.01

  36. 8-K · Current report

    Report date 2025-08-13 · 0001213900-25-075678 · Items 2.02,9.01

  37. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001213900-25-075635

  38. 8-K · Current report

    Report date 2025-07-08 · 0001213900-25-062194 · Items 2.05,5.02,8.01,9.01

  39. 8-K · Current report

    Report date 2025-07-07 · 0001213900-25-061632 · Items 8.01,9.01

  40. 8-K · Current report

    Report date 2025-07-03 · 0001213900-25-061471 · Items 5.07

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-07 · 1614 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001788028Jasper Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-07 · 1179 checked identities; 0 unavailable records

Search names and former names
  • Amplitude Healthcare Acquisition Corp · former SEC name · 2019-09-13 to 2021-09-29

Revenue in constant purchasing power

USD revenue expressed in 2026-08 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-10-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗